Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intended Use Study of the BD SurePath Plus™ Pap

NCT01234480 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.

NCT NCT01234480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01234480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intended Use Study of the BD SurePath Plus™ Pap
Lead sponsor
Becton, Dickinson and Company
Phase
Not reported
Overall status
Terminated
Start date
September 30, 2010
Completion date
August 31, 2012
Enrollment
5,859 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms, neoplasms by histologic type, neoplasms, glandular and epithelial, neoplasms, squamous cell, papilloma, uterine cervical cancer, uterine cervical neoplasms